EU Medicines Agency

‼️ EMA's human medicines committee #CHMP :

#Nomegestrol & #chlormadinone should be used with caution to treat gynaecological conditions, as hormone replacement therapy or as oral contraceptive to reduce the risk of #meningioma.

👉 https://www.ema.europa.eu/en/news/new-measures-minimise-risk-meningioma-medicines-containing-nomegestrol-chlormadinone

🐦🔗: https://nitter.eu/EMA_News/status/1565619233169588224

New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone - European Medicines Agency

New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone

European Medicines Agency
Sep 2, 2022 at 9:47amWeb